Drinking coffee or tea may be beneficial for physical function in ageing   

06 Aug 2025

NUS and Harvard study: Lifestyle Changes Can Cut Cardiovascular Disease Risk by Nearly 90% in Women with Gestational Diabetes History

A landmark study led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and Harvard T.H. Chan School of Public Health found that women with a history of gestational diabetes mellitus (GDM) can slash their risk of future cardiovascular disease (CVD) considerably through sustained healthy lifestyle habits.

04 Aug 2025

Journal of Medical Ethics is world’s leading bioethics journal, according to new rankings

The Journal of Medical Ethics (JME), published by BMJ, has just been ranked the number 1 bioethics journal in the world according to the 2025 Google Scholar Metrics, reaffirming its status as the leading global platform for cutting-edge work in medical and bioethics. The journal is co-led by Associate Professor Brian D Earp, Director of the EARP Lab (Experimental Bioethics, Artificial Intelligence, and Relational Moral Psychology Lab) within the Centre for Biomedical Ethics (CBmE), based at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine). He recently took up the role of Co-Editor-in-Chief alongside Professor Lucy Frith, University of Manchester, and Associate Professor Arianne Shahvisi, Brighton & Sussex Medical School.

31 Jul 2025

Healthy longevity in Singapore: Public demand, policy opportunity

Understanding public awareness, behaviours, and attitudes toward Healthy Longevity Medicine, also called Precision Geromedicine, is essential for shaping future health strategies. This emerging field aims to optimise health and extend the healthy lifespan by addressing the biological processes of ageing throughout a person's life.

17 Jul 2025

NUS-led global study shows longer brain scans lower research costs, provide more accurate predictions

A study – published in the journal Nature – led by Associate Professor Thomas Yeo from the Centre for Sleep and Cognition, Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), now offers a clear answer: 30-minute functional MRI (fMRI) scans deliver up to 22% in cost savings while still retaining or even improving prediction accuracy.

26 Jun 2025

New Singapore study to assess growing prevalence and impact of food allergies

This study will provide an update to existing data on food allergy prevalence, and for the first time, evaluate the impact, as well as the social and economic burden, of food allergies in Singapore. With these new insights, the hope is to bring greater social and infrastructural support for affected children and families. The study consists of two years of recruitment and two years of data analysis.

23 Jun 2025

Assoc Prof Brian D Earp appointed co-editor-in-chief for JME

Associate Professor Brian D. Earp of the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has been appointed the next Co-Editor-in-Chief of the Journal of Medical Ethics (JME), one of the world’s leading platforms for ethical scholarship in medicine and healthcare. An Associate Professor of Biomedical Ethics in the Centre for Biomedical Ethics at NUS Medicine, Assoc Prof Earp also holds courtesy appointments as Associate Professor of Philosophy and of Psychology at NUS, reflecting his wide-ranging interdisciplinary expertise. Before joining NUS, Assoc Prof Earp was a Senior Research Fellow in the Faculty of Philosophy at the University of Oxford. He is an elected member of the UK Young Academy, an initiative of the British Academy and the Royal Society, recognising early-career researchers of exceptional achievement and promise. At NUS, he directs both the Oxford-NUS Centre for Neuroethics and Society and the EARP Lab (Experimental Bioethics, Artificial Intelligence, and Relational Moral Psychology Lab).

20 Jun 2025

More than just menopause – How muscle, fat and a simple blood test can predict midlife women’s health

New research from the Integrated Women’s Health Programme (IWHP) at the National University Hospital (NUH) and the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), has uncovered new insights into how muscle strength and visceral fat, and their association with menopause, can potentially lead to downstream health impacts among women in Singapore, and how physical performance assessments and a simple blood test could help predict and prevent chronic conditions before they arise.

16 Jun 2025

NUS Medicine study finds key blood proteins which predict future cognitive decline

In a study that holds significance for individuals with cerebrovascular disease, scientists from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have found proteins in the blood that predict future cognitive decline and dementia. Led by Professor Christopher Chen, Deputy Chair of the Healthy Longevity Translational Research Programme (TRP) at NUS Medicine, this first-of-its-kind study in Singapore analysed more than 1,000 proteins in the blood of a local patient cohort. The study was conducted on 528 patients from memory clinics at the National University Hospital (NUH) and St Luke’s Hospital in Singapore. Professor Arthur Mark Richards, co-senior author of the paper published in Alzheimer’s and Dementia, said, “One of our findings was the characterisation of a blood protein signature for future cognitive decline. Using advanced proteomic technologies, we profiled over a thousand blood proteins tied to neurodegeneration, inflammation, and vascular dysfunction, which are key contributors to dementia.” Prof Richards is from the Cardiovascular-Metabolic Diseases TRP at NUS Medicine.

12 Jun 2025

Repurposed cancer drugs found to promote stroke recovery, limit brain damage

A recent study by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), has shown that a class of drugs, HDACi (histone deacetylase inhibitors), protects neurons and limits brain damage following stroke by altering the gene expression of microglia, the immune cells of the brain. HDACi are currently used or being tested as treatments for certain cancers and are also being researched for neurological conditions such as Alzheimer’s disease.

11 Jun 2025

AI designs drug combinations specifically for women or men to optimise heart valve disease treatment